Eli Lilly and Company (LLY) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 965.06B |
| Enterprise Value | 1T |
| P/E Ratio | 40.1 |
| PEG Ratio | 0.31 |
| Price/Sales Ratio | 14.77 |
| Price/Book Ratio | 32.49 |
| Enterprise/Revenue | 15.3 |
| Enterprise/EBITDA | 33.35 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.35 |
| Operating Margin | 0.46 |
| Return On Assets | 0.22 |
| Return On Equity | 1.01 |
| Revenue | 65.18B |
| Revenue/Share | 80.77 |
| Gross Profit | 54.62B |
| EBITDA | 27.94B |
| Net Income | 20.64B |
| Diluted EPS | 22.95 |
| Total Cash | 5.28B |
| Total Cash/Share | 5.9 |
| Total Debt | 43.37B |
| Total Debt/Equity | 1.39 |
| Current Ratio | 1.5 |
| Book Value Per Share | 34.88 |
| 52-Week Change | 40.3 |
| 52-Week High | 1,182.73 |
| 52-Week Low | 623.78 |
| Moving Average 50 Days | 996.78 |
| Moving Average 200 Days | 958.45 |
| Average Volume | 3.23M |
| Shares Outstanding | 941.74M |
| % Held by Institutions | 86.41 |
| Trailing Annual Dividend Rate | 6.46 |
| Trailing Annual Dividend Yield | 0.57 |
| Payout Ratio | 0.22 |
| Last Split Factor | 2:1 |
| Last Split Date | October 16, 1997 |